Zura Bio Valuation
| ZURA Stock | 2.92 0.00 0.00% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Zura Bio Limited maintains a prevalent Real Value of USD6.3 per share. The last-minute price of the company is USD2.92. Our model calculates the value of Zura Bio Limited from examining the company fundamentals such as Return On Asset of -0.21, current valuation of 189.69 M, and Shares Owned By Insiders of 31.87 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Zura Bio's valuation include:
Price Book 1.2372 | Enterprise Value 189.7 M | Enterprise Value Ebitda (2.34) | Trailing PE 7.9474 |
Undervalued
Today
Please note that Zura Bio's price fluctuation is moderately volatile at this time. Calculation of the real value of Zura Bio Limited is based on 3 months time horizon. Increasing Zura Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zura Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zura Stock. However, Zura Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.92 | Real 6.3 | Target 16.6 | Hype 2.93 | Naive 2.22 |
The real value of Zura Stock, also known as its intrinsic value, is the underlying worth of Zura Bio Limited Company, which is reflected in its stock price. It is based on Zura Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Zura Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Zura Bio Limited helps investors to forecast how Zura stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zura Bio more accurately as focusing exclusively on Zura Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Zura Bio's intrinsic value based on its ongoing forecasts of Zura Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Zura Bio's closest peers. If more than one evaluation category is relevant for Zura Bio we suggest using both methods to arrive at a better estimate.
Zura Bio Cash |
|
Zura Valuation Trend
Comparing Zura Bio's enterprise value against its market capitalization is a good way to estimate the value of Zura Bio Limited uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Zura Bio Total Value Analysis
Zura Bio Limited is at this time projected to have valuation of 189.69 M with market capitalization of 295.78 M, debt of 21.29 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Zura Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
189.69 M | 295.78 M | 21.29 M |
Zura Bio Asset Utilization
One of the ways to look at asset utilization of Zura is to check how much profit was generated for every dollar of assets it reports. Zura Bio Limited maintains a negative usage of resources of -0.21 (%), losing USD0.00214 for each dollar of resources held by the company. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it maintains. Specifically, asset utilization of Zura Bio Limited shows how discouraging it operates for each dollar spent on its resources.Zura Bio Ownership Allocation
Zura Bio Limited retains a total of 63.77 Million outstanding shares. Over half of Zura Bio's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Zura Bio Profitability Analysis
Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Zura Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Zura Bio and how it compares across the competition.
About Zura Bio Valuation
The stock valuation mechanism determines Zura Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Zura Bio. We calculate exposure to Zura Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Zura Bio's related companies.Zura Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 33.1 M |
Zura Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Zura Bio Limited and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Zura we look at many different elements of the entity such as Zura's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Zura Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Zura Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Zura Bio's worth.Complementary Tools for Zura Stock analysis
When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |